Suggestions
Marc Beer
Healthcare Entrepreneur & Board Member
Marc Beer is a seasoned executive with over 30 years of experience in therapeutic development and commercialization.12 He currently serves as the Chairman of Papyrus Therapeutics Inc., a position he has held since August 2021.3 Papyrus Therapeutics is an emerging biopharma company developing novel tumor suppressor-based therapies.3
In addition to his role at Papyrus Therapeutics, Marc Beer holds several other prominent positions:
- Chairman of BioTE Medical since January 20213
- Chairman of Origami Surgical since April 20203
- Co-Founder and Chairman of LumeNXT LLC since August 20183
- Strategic Advisor at Renovia Inc., a company he co-founded in 20163
Beer has a notable track record in the healthcare and biotechnology sectors. He was the CEO of Aegerion Pharmaceuticals from 2010 to 20153 and the CEO of ViaCell from 2000 to 2007.3 He also served as the Chairman of Minerva Neurosciences from 2013 to 2018.3
Marc Beer received his undergraduate degree from Miami University.2 His extensive experience and leadership roles in various healthcare companies demonstrate his expertise in the development and commercialization of innovative medical technologies and therapies.
Highlights
Congratulations to the Origami Team on this 422 patient study published by Dr. Kim Kenton, Dr. Sarah Collins and their team, on the safety and efficacy of using StitchKit in robotic Sacrocolpopexy surgery.
Read more here:
Allison Aubrey’s report of the impressive research Dr. Douglas Vaughan and Dr. John Wilkins are doing at the Longevity Institute provides a remarkable insight into the biology of aging and how to age well. I wholeheartedly agree we are nearing breakthroughs in discovering interventions that will help us slow the rate of aging and extend our health span. Companies like Biote have been demonstrating for years the remarkable benefits of hormone optimization in areas of aging once thought to be inevitable, adding to the body of clinical research and real-life successes. Evolving its leadership position in 2024 to a broader mission of evidence-based wellness to support healthy aging, Biote is demonstrating that the more we understand the triggers and levers in our DNA, lifestyle and environment, the more we can slow biological aging. That’s the real “inevitable.”
Read the full article on NPR here: https://lnkd.in/eP9vjSfb #health #healthcare #healthspan #future #aging
